CD8A and neoplasm: Immunologically, the analysis of tumor microenvironment inflammation has revealed an incidence of strong antigen and T-cell activation, leading to the development of tumor-specific CD8+ T cells capable of eliminating cancer cells and in developing long-term antitumor memory responses [32].